Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending September 28, 2005. The report serves as a notification of transactions involving a Person Discharging Managerial Responsibility (PDMR) in accordance with Disclosure Rule 3.1.4R(1)(a).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification regarding share transactions and does not contain financial performance data.
Material Changes
The only material change reported is the exercise of share options by Mr. D Pulman on September 27, 2005. He exercised options over 7,046 Ordinary shares granted on August 14, 1996, under the Glaxo Wellcome International Share Option Scheme at an exercise price of GBP 8.94 per share.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the disclosure of the specific share transaction mentioned above.
Key Facts for Investor Verification
- Transaction Date: September 27, 2005.
- Individual: Mr. D Pulman (Person Discharging Managerial Responsibility).
- Transaction Type: Exercise of share options.
- Share Count: 7,046 Ordinary shares.
- Exercise Price: GBP 8.94 per share.
- Original Grant Date: August 14, 1996.